Stock listing
Entropy Neurodynamics Limited
Selected listing: ENP · ASX · AUD · AU
Entropy Neurodynamics Limited (ASX:ENP), Health Technology. Latest release Oct 6, 2026: TRP-8803 60-Minute Infusion Achieved in Phase 2 BED Study.
- Ticker
- ASX:ENP
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- ASX
- Currency
- AUD
About Entropy Neurodynamics Limited
The company focuses on developing innovative solutions in the field of neurodynamics. Its commitment to advancing technology in this sector positions it as a notable player in the industry.
Latest news from Entropy Neurodynamics Limited
TRP-8803 60-Minute Infusion Achieved in Phase 2 BED Study
October 6, 2026
All Patients Improve, 50% Achieve 12-Week BED Remission
September 13, 2026
Appendix 4E and 2026 Annual Report
August 27, 2026
Entropy Advances TRP-8803 to US Phase 2 in Depression
August 25, 2026
TRP 8803 manufacturing secured for Phase 2/3 advancement
August 18, 2026
Research Entropy Neurodynamics Limited
Entropy Neurodynamics Limited company profile
View the public company page for Entropy Neurodynamics Limited on 6ix.
Entropy Neurodynamics Limited news
Read company news and market updates connected to Entropy Neurodynamics Limited.
Entropy Neurodynamics Limited investor events
Find investor webinars, events, and replay context for Entropy Neurodynamics Limited.